AVITA SHARE PRICE News & Analysis

Analysts say the incident has given the medical device company a 'rare opportunity’ to expand its market share.

The single-product company is high-risk, high-reward.

Morningstar is looking past the reported net loss to increased use of the company’s flagship spray-on skin therapy.

The corona sell-off hurt the spray-on-skin maker but it’s got an eye on the bigger picture, says Nicolette Quinn

The corona sell-off has unearthed discounts among makers of gloves, pharmaceutical goods and spray-on skin technology.

Spray-on skin maker Avita Medical has a chance of becoming the new standard in burns treatment, says Morningstar's Nicolette Quinn. 

Spray-on-skin maker Avita has had runaway success on the ASX. And it's not done yet, says Morningstar's Nicolette Quinn.

Demand for coal is expected to rise in Asia, while regenerative skin maker Avita is gaining ground in the US.